Sun Pharma.Inds. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
13,752.00
11,087.00
9,408.00
4,481.00
2,799.00
5,009.00
Adjustment
1,120.00
1,554.00
2,722.00
1,974.00
1,809.00
1,992.00
Changes In working Capital
-323.00
1,062.00
-5,661.00
1,559.00
2,564.00
898.00
Cash Flow after changes in Working Capital
14,548.00
13,704.00
6,469.00
8,015.00
7,173.00
7,900.00
Cash Flow from Operating Activities
14,072.00
12,134.00
4,959.00
8,984.00
6,170.00
6,554.00
Cash Flow from Investing Activities
-5,183.00
-762.00
-7,219.00
-5,555.00
406.00
-2,225.00
Cash Flow from Financing Activities
-7,905.00
-6,710.00
2,376.00
-5,193.00
-5,980.00
-5,715.00
Net Cash Inflow / Outflow
983.00
4,661.00
115.00
-1,764.00
596.00
-1,385.00
Opening Cash & Cash Equivalents
9,285.00
4,623.00
4,508.00
6,273.00
5,676.00
7,062.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
10,268.00
9,285.00
4,623.00
4,508.00
6,273.00
5,676.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sun Pharma.Inds.
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
13752.13
2916
10,836.00
371.61%
Adjustment
1120.36
115
1,005.00
874.23%
Changes In working Capital
-323.56
-554
231.00
41.60%
Cash Flow after changes in Working Capital
14548.93
2477
12,071.00
487.36%
Cash Flow from Operating Activities
14072.09
1653
12,419.00
751.31%
Cash Flow from Investing Activities
-5183.15
-804
-4,379.00
-544.67%
Cash Flow from Financing Activities
-7905.82
-799
-7,106.00
-889.46%
Net Cash Inflow / Outflow
983.12
50
933.00
1866.24%
Opening Cash & Cash Equivalents
9285.65
363
8,922.00
2458.03%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
10268.77
413
9,855.00
2386.38%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 15.96% vs 144.69% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
14,072.09
12,134.98
15.96%






